FDA.reportPublic FDA data

0.5 ML tirzepatide 20 MG/ML Injection [Zepbound]

RxCUI
2679317
RxNorm name
0.5 ML tirzepatide 20 MG/ML Injection [Zepbound]
Display name
0.5 ML tirzepatide 20 MG/ML Injection [Zepbound]
Full name
0.5 ML tirzepatide 20 MG/ML Injection [Zepbound]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZepboundTIRZEPATIDEEli Lilly and Company487cd7e7-434c-4925-99fa-aa80b1cc776b2026-04-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2679317

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776bzepbound 10 MG in 0.5 ML Injection [PSN] · 0.5 ML tirzepatide 20 MG/ML Injection [Zepbound] [SBD] · Zepbound 10 MG per 0.5 ML Injection [SY]338These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422